Trial · NCT00736099
Results by group116
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 116
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Frequency of Patients With Adverse Events (AEs) | Old Lina | Patients with any AEs | 1253 | Participants | |
| Frequency of Patients With Adverse Events (AEs) | New Lina | Patients with any AEs | 465 | Participants | |
| Frequency of Patients With Adverse Events (AEs) | Old Lina | Patients with severe AEs | 57 | Participants | |
| Frequency of Patients With Adverse Events (AEs) | New Lina | Patients with severe AEs | 23 | Participants | |
| Frequency of Patients With Adverse Events (AEs) | Old Lina | Patients with withdrawal due to AEs (from AE page) | 57 | Participants | |
| Frequency of Patients With Adverse Events (AEs) | New Lina | Patients with withdrawal due to AEs (from AE page) | 16 | Participants | |
| Frequency of Patients With Investigator-defined Hypoglycaemic Adverse Events | Old Lina | 209 | Participants | ||
| Frequency of Patients With Investigator-defined Hypoglycaemic Adverse Events | New Lina | 86 | Participants | ||
| Frequency of Patients With Significant Adverse Events Based on Standardised MedDRA Query (SMQ) | Old Lina | Renal AEs | 20 | Participants | |
| Frequency of Patients With Significant Adverse Events Based on Standardised MedDRA Query (SMQ) | New Lina | Renal AEs | 10 | Participants | |
| Frequency of Patients With Significant Adverse Events Based on Standardised MedDRA Query (SMQ) | Old Lina | Hypersensitivity reactions | 7 | Participants | |
| Frequency of Patients With Significant Adverse Events Based on Standardised MedDRA Query (SMQ) | New Lina | Hypersensitivity reactions | 3 | Participants | |
| Frequency of Patients With Significant Adverse Events Based on Standardised MedDRA Query (SMQ) | Old Lina | Hepatic AEs | 21 | Participants | |
| Frequency of Patients With Significant Adverse Events Based on Standardised MedDRA Query (SMQ) | New Lina | Hepatic AEs | 5 | Participants | |
| Frequency of Patients With Significant Adverse Events Based on Standardised MedDRA Query (SMQ) | Old Lina | Severe cutaneous adverse reactions | 0 | Participants | |
| Frequency of Patients With Significant Adverse Events Based on Standardised MedDRA Query (SMQ) | New Lina | Severe cutaneous adverse reactions | 0 | Participants | |
| Frequency of Patients With Significant Adverse Events Based on Standardised MedDRA Query (SMQ) | Old Lina | Pancreatitis | 4 | Participants | |
| Frequency of Patients With Significant Adverse Events Based on Standardised MedDRA Query (SMQ) | New Lina | Pancreatitis | 0 | Participants | |
| Frequency of Patients With Adjudication of Cardiac and Cerebrovascular Events | Old Lina | 82 | participants | ||
| Frequency of Patients With Adjudication of Cardiac and Cerebrovascular Events | New Lina | 37 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00736099/results